Literature DB >> 2646986

Dose-response relationships of doxacurium chloride in humans during anesthesia with nitrous oxide and fentanyl, enflurane, isoflurane, or halothane.

J A Katz1, R J Fragen, C A Shanks, K Dunn, B McNulty, G D Rudd.   

Abstract

In a two-part study, the dose-response relationships of doxacurium chloride (BW A938U) were evaluated during general anesthesia maintained with commonly used anesthetic techniques. In part 1, cumulative dose-response methodology was used to establish the ED95 of doxacurium in 36 patients receiving 70% nitrous oxide and fentanyl, or 50% nitrous oxide and either 1.26% enflurane, 0.84% isoflurane, or 0.57% halothane anesthesia. Mechanomyographic response to train-of-four stimulation was used to monitor neuromuscular blockade. The peak effect of doxacurium following each 5 micrograms/kg incremental dose was noted and a log-probit dose-response curve was constructed for each individual patient. The median ED50s were 11 micrograms/kg, 6 micrograms/kg, 8 micrograms/kg, and 8 micrograms/kg for patients receiving fentanyl, enflurane, isoflurane, or halothane anesthesia, respectively. The median ED95s were 24 micrograms/kg, 14 micrograms/kg, 16 micrograms/kg, and 19 micrograms/kg for patients receiving fentanyl, enflurane, isoflurane, and halothane anesthesia, respectively. In part 2, 72 additional patients received a rapid single injection of the ED95 (n = 36) or 2 X ED95 (n = 36) of doxacurium appropriate for the administered anesthetic as estimated from part one of the study. Peak effects of the ED95 given as single injections correlated well with the results in part 1.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2646986     DOI: 10.1097/00000542-198903000-00012

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  5 in total

Review 1.  Doxacurium. A review of its pharmacology and clinical potential in anaesthesia.

Authors:  D Faulds; S P Clissold
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

Review 2.  Neuromuscular transmission and its pharmacological blockade. Part 2: Pharmacology of neuromuscular blocking agents.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

3.  Pharmacodynamics of doxacurium during cardiac surgery with hypothermic cardiopulmonary bypass.

Authors:  P McDonagh; J Y Dupuis; M Curran; J Kitts; J E Wynands
Journal:  Can J Anaesth       Date:  1996-02       Impact factor: 5.063

Review 4.  Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.

Authors:  R K Mirakhur
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

5.  Reversal of doxacurium and pancuronium neuromuscular blockade with neostigmine in children.

Authors:  J C Bevan; J P Purday; E J Reimer; D R Bevan
Journal:  Can J Anaesth       Date:  1994-11       Impact factor: 5.063

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.